je.st
news
Insys CEO Babich resigns, drugmaker tops 3Q expectations
2015-11-05 19:25:14| Biotech - Topix.net
Michael L. Babich has resigned as president and CEO of Insys Therapeutics, a specialty drugmaker under investigation over sales of its powerful painkiller Subsys. Shares of the Chandler, Arizona, company jumped almost 10 percent Thursday morning as the company also announced third-quarter earnings that trumped analyst expectations and said it was buying back some stock.
Tags: ceo
expectations
tops
resigns
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||